- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Jeff Dale2024-03-28T21:11:00
A Missouri-based healthcare laboratory and three of its owners agreed to pay approximately $13.6 million to settle charges levied by the Department of Justice (DOJ) of violating the False Claims Act by improperly billing Medicare for tests that were not ordered or medically necessary.
Gamma Healthcare and the owners, Jerry Murphy, Jerrod Murphy, and Joel Murphy, agreed to pay the civil penalty, while the company, Jerry Murphy, and Jerrod Murphy also agreed to a 15-year ban from participating in federal healthcare programs, the DOJ announced in a press release Wednesday.
The settlement resolves claims brought under the qui tam provisions of the False Claims Act by Bradley Bibb, a physician whose clinics provided services to patients for whom Gamma performed laboratory tests. Bibb will receive about $2.3 million from the settlement.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
A Minnesota dermatology practice, its owner, and chief executive agreed to pay $1.6 million to settle allegations, first brought by two whistleblowers, that the company violated the Anti-Kickback Statue by making false claims to Medicare.
The Department of Justice ordered Cape Cod Hospital to pay nearly $24.4 million to settle alleged False Claims Act violations that it knowingly submitted claims to the government for procedures that failed to comply with Medicare rules.
Florida-based Baptist Health System agreed to pay $1.5 million to settle self-disclosed violations of the False Claims Act for allegedly offering discounts to patients to induce purchases or refer services reimbursed by Medicare.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
